Market Overview

McNicoll Lewis & Vlak Raises PT on AMAG Pharmaceuticals to $23


McNicoll Lewis & Vlak has raised the price target on AMAG Pharmaceuticals (NASDAQ: AMAG) to $23 and maintains its Buy rating.

Posted-In: mcnicoll lewis vlakPrice Target Intraday Update Analyst Ratings


Related Articles (AMAG)

View Comments and Join the Discussion!

Get Benzinga's Newsletters